Histologically confirmed breast cancer, completely excised
Natural or iatrogenic menopausal status
No evidence of distant metastasis
Self-identified moderate to severe symptoms of genitourinary syndrome
Normal kidney and liver function
Written Informed Consent signed and dated by patient
Negative Papanicolau (Pap) Smear Cytology Test within 1 year prior to enrollment
You may not be if
Vaginal or uterine bleeding of unknown origin
Current diagnosis of any non-breast malignancy
Metastatic disease
Currently on chemiotherapy
Currently on treatment with tamoxifen
Mentally incompetent or evidence of active substance or alcohol abuse
Endometrial hyperplasia
Pregnancy or lactation
Currently use of other vaginal therapy for the same purpose (if present, they have to be stopped 15 days before baseline visit)
Clinically significant metabolic or endocrine disease not controlled by medication
Clareo Health | Effect of Intravaginal Prasterone on Symptoms of Genitourinary Syndrome of Menopause (GSM) in Women in Menopause With Previous Breast Cancer
